197 related articles for article (PubMed ID: 12184530)
1. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.
Bozkaya H; Yurdaydin C; Törüner M; Arat M; Bozdayi AM; Erekul S; Cinar K; Koç H; Uzunalimoğlu O
Dig Dis Sci; 2002 Aug; 47(8):1782-5. PubMed ID: 12184530
[TBL] [Abstract][Full Text] [Related]
2. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
Yaşar DG; Suyanı E; Özenirler S; Sucak GT
Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia.
Chen HF; Xu BX; Shen HS; Li ZY; Jin LJ; Tang JQ; Wang J; Zhu JJ; Qin LM; Cui QY; Ren YY; Wu TQ
Drug Des Devel Ther; 2014; 8():1299-305. PubMed ID: 25246771
[TBL] [Abstract][Full Text] [Related]
4. Resolution of acute hepatitis B-associated aplastic anaemia with antiviral therapy.
Hendren N; Moore J; Hofmann S; Rambally S
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28974509
[TBL] [Abstract][Full Text] [Related]
5. [Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].
Mikhaĭlova EA; Iadrikhinskaia VN; Savchenko VG
Ter Arkh; 1999; 71(7):64-9. PubMed ID: 10481870
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of hepatitis B virus associated nephrotic syndrome with oral Lamivudine in a Nigerian child: a case report.
Ladapo TA; Onifade EU; Lesi AE; Lesi OA
J Trop Pediatr; 2012 Apr; 58(2):157-8. PubMed ID: 21624925
[TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis B and aplastic anemia.
Nakamura S; Sato T; Maeda T; Sato Y
Tohoku J Exp Med; 1975 May; 116(1):101-2. PubMed ID: 1154371
[TBL] [Abstract][Full Text] [Related]
8. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
[No Abstract] [Full Text] [Related]
9. The Impact of Hepatitis on Clinical Outcomes for Pediatric Patients with Aplastic Anemia.
Wang WH; Wu JF; Chang HH; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST
J Pediatr; 2020 Dec; 227():87-93.e2. PubMed ID: 32805258
[TBL] [Abstract][Full Text] [Related]
10. Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
Ng YY; Yang WC; Lee ST
Kidney Int; 2006 Feb; 69(4):776. PubMed ID: 16518335
[No Abstract] [Full Text] [Related]
11. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis-associated aplastic anemia.
Brown KE; Tisdale J; Barrett AJ; Dunbar CE; Young NS
N Engl J Med; 1997 Apr; 336(15):1059-64. PubMed ID: 9091802
[TBL] [Abstract][Full Text] [Related]
13. Aplastic anemia associated with type B viral hepatitis.
Casciato DA; Klein CA; Kaplowitz N; Scott JL
Arch Intern Med; 1978 Oct; 138(10):1557-8. PubMed ID: 708179
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation.
Picardi M; Selleri C; De Rosa G; Raiola A; Pezzullo L; Rotoli B
Bone Marrow Transplant; 1998 Jun; 21(12):1267-9. PubMed ID: 9674862
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays.
Cariani E; Pelizzari AM; Rodella A; Gargiulo F; Imberti L; Manca N; Rossi G
J Hepatol; 2007 Apr; 46(4):743-7. PubMed ID: 17316877
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.
Liaw YF; Chien RN; Yeh CT; Tsai SL; Chu CM
Hepatology; 1999 Aug; 30(2):567-72. PubMed ID: 10421670
[TBL] [Abstract][Full Text] [Related]
17. Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia.
Dai MS; Kao WY; Shyu RY; Chao TY
J Viral Hepat; 2004 May; 11(3):283-5. PubMed ID: 15117333
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation after a resolutive acute hepatitis leading to a diagnosis of T cell lymphoma.
Negreanu L; Baty G; Dubois F; de Muret A; Bacq Y
Dig Liver Dis; 2009 Jul; 41(7):e39-41. PubMed ID: 18819852
[TBL] [Abstract][Full Text] [Related]
19. Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
Arcaini L; Merli M; Rattotti S; Bruno R; Vercelli A; Lucioni M; Riboni R; Paulli M
J Clin Oncol; 2011 Jun; 29(18):e543-5. PubMed ID: 21482990
[No Abstract] [Full Text] [Related]
20. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
